Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

James River Group Holdings Ltd (JRVR): Are Hedge Funds Right About This Stock?

Page 1 of 2

Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse of whether that stock could make for a good addition to our portfolios. The odds are not exactly stacked in investors’ favor when it comes to beating the market, as evidenced by the fact that less than 49% of the stocks in the S&P 500 did so during the 12-month period ending October 30. However, 63% of hedge funds’ top 30 stock picks from the index did beat the market, and returned nearly twice as much on average as the index. Thus, we can see that the tireless research and efforts of hedge funds to identify winning stocks can work to our advantage when we know how to use the data. While not all of their picks will be winners, our odds are much better following their best stock picks than trying to go it alone.

Is James River Group Holdings Ltd (NASDAQ:JRVR) an outstanding investment today? The best stock pickers are taking a bullish view. The number of long hedge fund positions improved by 4 lately. At the end of this article we will also compare JRVR to other stocks including Kforce Inc. (NASDAQ:KFRC), Square 1 Financial Inc (NASDAQ:SQBK), and Coherus Biosciences Inc (NASDAQ:CHRS) to get a better sense of its popularity.

Follow James River Group Holdings Ltd. (NASDAQ:JRVR)
Trade (NASDAQ:JRVR) Now!

Now, let’s take a glance at the recent action surrounding James River Group Holdings Ltd (NASDAQ:JRVR).

How are hedge funds trading James River Group Holdings Ltd (NASDAQ:JRVR)?

Heading into Q4, a total of 13 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of 44% from one quarter earlier. With hedge funds’ positions undergoing their usual ebb and flow, there exists an “upper tier” of noteworthy hedge fund managers who were increasing their holdings significantly (or already accumulated large positions).

Of the funds tracked by Insider Monkey, D. E. Shaw’s D E Shaw has the largest position in James River Group Holdings Ltd (NASDAQ:JRVR), worth close to $377.7 million, comprising 0.6% of its total 13F portfolio. Coming in second is Ken Griffin of Citadel Investment Group, with an $20.3 million position; less than 0.1%% of its 13F portfolio is allocated to the company. Remaining peers with similar optimism encompass Israel Englander’s Millennium Management, Anand Parekh’s Alyeska Investment Group and Porter Collins, Daniel Moses, and Vincent Daniel’s Seawolf Capital.

Now, some big names were breaking ground themselves. ZWEIG DIMENNA PARTNERS, managed by Joe DiMenna, initiated the biggest position in James River Group Holdings Ltd (NASDAQ:JRVR). ZWEIG DIMENNA PARTNERS had $4.7 million invested in the company at the end of the quarter. Millennium Management Subsidiary’s Blue Arrow Capital Management also initiated an $1.3 million position during the quarter. The following funds were also among the new JRVR investors: Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital, Chao Ku’s Nine Chapters Capital Management, and Jim Simons’s Renaissance Technologies.

On the next page, we take a look at hedge fund activity in other stocks – not necessarily in the same industry as James River Group Holdings Ltd (NASDAQ:JRVR) but similarly valued.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!